ClinicalTrials.gg
CompletedNCT03943277Updated Dec 5, 2024

Usefulness of White Blood Cell Count (WBCC) During Infection in Geriatric Patient

An observational study in White Blood Cells Engulfing Red Blood Cells, sponsored by Universitair Ziekenhuis Brussel. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-05.

Sponsored by Universitair Ziekenhuis Brussel · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
62
Ages
18 Years and older
Sex
All
01

Study summary

In the general population, increased WBCC and neutrophil count are widely used as markers for infection during inflammatory states 1. However, 32% of geriatric patients with an infection do not develop an increase in WBCC 2. The hypothesis is that with inflammation, geriatric patients have a misadapted response of the immune system (IS) 3.

Our recent retrospective study 4 has shown that total and differential WBCC were not correlated with infection in a geriatric hospitalized population. Therefore, WBCC does not seem to be a reliable marker for infection in geriatric hospitalized patients. The neutrophil/lymphocyte ratio, and CRP, seem to be better markers.

the aim of the study to investigate this hypothesis prospectively and assess the role of aging and chronic diseases (such as cardiovascular diseases (CVD) and risk factors (CVRF) 5, cytomegalovirus (CMV) infection 6, periodontitis 7, onychomycosis 8 ) in this process and assess the role of a geriatric assessment.

To assess the usefulness of WBCC in the diagnosis of infection in geriatric patients and to address the contribution of ongoing chronic co-morbidities and age to WBCC-kinetics during an acute inflammatory syndrome, young and geriatric hospitalized patients with an inflammatory syndrome with and without infection will be compared

Read the detailed description

Study design Observational prospective study

The subjects Number of subjects 200 subjects: Average value CRP: group 1: 55; group 2: 84 Average standard deviation: 70.52 Power 80%: 158 deelnemers Power 90%: 202 deelnemers alpha = 0.05 2-sample T-test.

Inclusion criteria

Acute inflammation is defined as a CRP ≥ 10 mg/l. We will include 2 groups of participants:

  • A) A group with an inflammatory syndrome and infection; infection being defined as:

    1. Viral infection confirmed by nasopharynx swab for: influenza, RSV, parainfluenza, rhinovirusses, coronavirusses.
    2. Bacterial infection confirmed with positive blood culture, positive articular punction, positive expectorations, pneumonia on chest radiograph, or infection documented by abdominal imagery (CT or echo), a positive urine culture with a confirmed pyelonephritis with a renal echography or a DMSA scintigraphy or specific clinical symptoms for pyelonephritis and positive hemoculture. A positive urine culture alone is not considered as urine infection because of the high prevalence of asymptomatic bacteriuria in geriatric patients.
  • B) A group with inflammatory syndrome and inflammatory diseases without infection: defined as:

    1. Confirmed pulmonary embolism (PE) by CT or ventilation-perfusion scintigraphy
    2. Microcrystalline arthritis diagnosed by articular punction
    3. Crush syndrome or rhabdomyolyses defined by history of a fall and raised creatine kinase in blood sample.

Exclusion criteria Immunosuppressive therapy (NSAIDs, corticosteroids, chemotherapy, immunotherapy), active cancer, antibiotics before admission, hematological diseases

Replacement of subjects None.

Restrictions and prohibitions for the subjects None.

Procedures

A) Questionnaires:

taken at UZ Brussels

  • Social: age, home, sex, marital status.
  • Clinical: smoking and alcohol habits, streptococcus pneumoniae and influenza vaccination status, allergies, BMI, medical history, current treatment, reason for current hospitalization.
  • Comprehensive geriatric assessment:
  • CIRS-G (Cumulative Illness Rating Score): to quantify disease burden. It rates each organ system on a scale of 0 to 4, and differentiates older adults with the highest risk of and severity of infection, from those with lower infection risk. 20
  • Katz scale (ADL: assessment of activities of daily living): It rates 6 tasks of daily living (bathing, dressing, toilet, transfer, continence and eating) on a scale from 1 to 4. A low score means absence of dependence, and a high score the maximum of dependence for the task. 21
  • MMSE (Mini Mental Status Examination): a 0-30 score of cognitive functions, \<24/30 meaning cognitive function impairment. 22 Patients with dementia:the investigators will request approval to be included in the study to the family of the patients.
  • MUST (Malnutrition Universal Screening Tool): to assess nutritional status. It divides patients into 3 groups: A low risk of malnutrition (score 0). A medium risk of malnutrition (score 1): then it is recommended to observe the patient for dietary intake. A high risk of malnutrition (score ≥2): treat the malnutrition. 23
  • Questionnaire for periodontal health. The newly developed questionnaire produces a reliable assessment of the individual risk of periodontitis (total score) and the need for periodontal treatment as well as the differentiation between gingivits and peridontitis. 24
  • Grip strength: Inflammatory states in the elderly are also associated with a decrease in muscle strength and fatigue resistance, as seen at UZ Brussels by Bautmans et al. The reduced strength and fatigue resistance in geriatric patients with inflammation are significantly related with the concentration of circulating CRP levels. 25 In the study, the investigators will use the martin vigorimeter which is at our disposal at the geriatrics ward of UZ Brussels, to measure the patients' grip strength and muscle fatiguability and determine which factors seem to contribute to a decrease in muscle strength (CRP, CVD, CVR, infection, periodontitis, CMV status, onychomycosis, age). the investigators will use the Martin vigorimeter (Elmed, Addison, IL) to assess grip strength and fatiguibility. The investigators will ask the patients to squeeze the rubber bulb of the vigorimeter as hard as possible in 3 consecutive attempts, to assess their grip strength. The highest score for each hand is recorded. Fatigue resistance will be assessed by asking the patient to squeeze the bulb of the vigorimeter as hard as possible and to maintain this pressure as long as possible; the time (seconds) until the pressure diminished to half of the maximal grip strength is recorded for each hand.25 26 B) Collection of data from physical examination C) Clinical evaluation of onychomycosis of the toenails: the investigators will perform a clinical examination of the toenails. Following parameters are found to be significantly related to positive mycology results in onychomycosis patients 8: scaling on one or both soles, white crumbly patches on the nail surface, and an abnormal colour of the nail.

D) Follow up of bacterial and viral culture analyses

Observational data from bacterial and viral samples during hospitatalization :

  1. Viral infection confirmed by nasopharynx swab for: influenza, RSV, parainfluenza, rhinovirusses, coronaviruses
  2. Bacterial infection confirmed with positive blood culture, positive articular punction, positive expectorations, pneumonia on chest radiograph, or infection documented by abdominal imagery (CT or echo), a positive urine culture with a confirmed pyelonephritis with a renal echography or a DMSA scintigraphy or specific clinical symptoms for pyelonephritis and positive hemoculture. A positive urine culture alone is not considered as urine infection because of the high prevalence of asymptomatic bacteriuria in geriatric patients.

E) Follow up of blood analyses:

Observational data from blood samples during hospitalization:

  • Day 0 (at the emergency department): CRP, total and differential WBCC, renal function
  • Day 1: at hospitalization, within 24h of admission
  • Geriatric patients: CRP, total and differential WBCC, renal function, hepatic function (transaminases), albumin, prealbumin, protein profile and monoclonal protein, vitamin B12, folic acid, hemoglobin, hematocrit, TSH, CMV-serology.
  • Young patients: CRP, total and differential WBCC, renal function, albumin, vitamin B12, folic acid, TSH, CMV-serology.
  • Day 3: CRP, total and differential WBCC.
  • Day 5: CRP, total and differential WBCC.

Flowchart Questionnaires, blood samples: conducted by Hanne Maes. Supervising MD: Dr. Nathalie Compté, UZ Brussels.

Randomisation/blinding Observational study, not applicable.

Prior and concomitant therapy All medication can be continued during this study.

Study analysis Statistical analysis the investigators will perform student t-tests or Mann-Whitney rank sum tests to compare geriatric/young patients with and without infection. To assess the contribution of age, comorbidities and geriatric syndrome in the kinetics of WBCC, the investigators will perform univariate and multivariate analyses.

02

Conditions studied

  • White Blood Cells Engulfing Red Blood Cells
03

In context

Lead sponsor

Universitair Ziekenhuis Brussel is the lead sponsor of 374 studies on the registry; 106 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Young and older patient with an inflammatory syndrome (CRP > 10 mg/dl) with or without infection

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Acute inflammation is defined as a CRP ≥ 10 mg/l. We will include 2 groups of participants:

  • A) A group with an inflammatory syndrome and infection; infection being defined as:

    1. Viral infection confirmed by nasopharynx swab for: influenza, RSV, parainfluenza, rhinovirusses, coronavirusses.
    2. Bacterial infection confirmed with positive blood culture, positive articular punction, positive expectorations, pneumonia on chest radiograph, or infection documented by abdominal imagery (CT or echo), a positive urine culture with a confirmed pyelonephritis with a renal echography or a DMSA scintigraphy or specific clinical symptoms for pyelonephritis and positive hemoculture. A positive urine culture alone is not considered as urine infection because of the high prevalence of asymptomatic bacteriuria in geriatric patients.
  • B) A group with inflammatory syndrome and inflammatory diseases without infection: defined as:

    1. Confirmed pulmonary embolism (PE) by CT or ventilation-perfusion scintigraphy
    2. Microcrystalline arthritis diagnosed by articular punction
    3. Crush syndrome or rhabdomyolyses defined by history of a fall and raised creatine kinase in blood sample.

Exclusion criteria

Exclusion Criteria:

Immunosuppressive therapy (NSAIDs, corticosteroids, chemotherapy, immunotherapy), active cancer, antibiotics before admission, hematological diseases

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
62 participants (actual)
Target follow-up
2 Weeks
Patient registry
Yes

Groups and cohorts

  • patient with infection

    Acute inflammation is defined as a CRP ≥ 10 mg/l. We will include 2 groups of participants: A group with an inflammatory syndrome and infection; infection being defined as: 1. Viral infection confirmed by nasopharynx swab for: influenza, RSV, parainfluenza, rhinovirusses, coronavirusses. 2. Bacterial infection confirmed with positive blood culture, positive articular punction, positive expectorations, pneumonia on chest radiograph, or infection documented by abdominal imagery (CT or echo), a positive urine culture with a confirmed pyelonephritis with a renal echography or a DMSA scintigraphy or specific clinical symptoms for pyelonephritis and positive hemoculture. A positive urine culture alone is not considered as urine infection because of the high prevalence of asymptomatic bacteriuria in geriatric patients.

    Other: No intervention, observational study

  • patient without infection

    Acute inflammation is defined as a CRP ≥ 10 mg/l. We will include 2 groups of participants: =\> B) A group with inflammatory syndrome and inflammatory diseases without infection: defined as: 1. Confirmed pulmonary embolism (PE) by CT or ventilation-perfusion scintigraphy 2. Microcrystalline arthritis diagnosed by articular punction 3. Crush syndrome or rhabdomyolyses defined by history of a fall and raised creatine kinase in blood sample.

    Other: No intervention, observational study

Interventions

  • OtherNo intervention, observational study

    No intervention observational study

06

What researchers measure

Primary outcomes

  1. Usefulness of white blood cell count (WBCC) during infection in geriatric patient

    observation of WBCC is correlated with infection by older patient

    Time frame: 1.5 years

  2. Delta of wbcc

    the significance of a Delta of WBCC (Delta= □((White blood cell count during acute infection or acute inflammatory events)/(White blood cell count in chronic circumstances)) ) in geriatric patients with acute infections or inflammatory events

    Time frame: 1.5 years

07

Study locations

1 site
  • UZ Brussel
    Brussels, 1090, Belgium
08

References and documents

Publications

  • Compte N, Dumont L, Bron D, De Breucker S, Praet JP, Bautmans I, Pepersack T. White blood cell counts in a geriatric hospitalized population: A poor diagnostic marker of infection. Exp Gerontol. 2018 Dec;114:87-92. doi: 10.1016/j.exger.2018.11.002. Epub 2018 Nov 6. PubMed 30412726 ↗
  • Compte N, Bailly B, De Breucker S, Goriely S, Pepersack T. Study of the association of total and differential white blood cell counts with geriatric conditions, cardio-vascular diseases, seric IL-6 levels and telomere length. Exp Gerontol. 2015 Jan;61:105-12. doi: 10.1016/j.exger.2014.11.016. Epub 2014 Nov 22. PubMed 25446500 ↗

Study documents

  • Protocol and statistical analysis plan · Feb 20, 2019
  • Informed consent form · Feb 20, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — data will be maybe described in an article

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03943277
Responsible party
Nathalie compté (Clinic head of geriatric unit, Universitair Ziekenhuis Brussel) — Principal investigator
First posted
May 9, 2019
Start date
May 20, 2019
Primary completion
Jun 30, 2024
Completion
Jun 30, 2024
Last update
Dec 5, 2024

Study contacts

Compté Nathalie, Dr, PhD
principal investigator · Universitair Ziekenhuis Brussel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion